Home Carboxes 100986-85-4
100986-85-4,MFCD00865049
Catalog No.:AA0003AY

100986-85-4 | 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
in stock  
$6.00   $4.00
- +
5g
97%
in stock  
$12.00   $8.00
- +
10g
97%
in stock  
$15.00   $11.00
- +
25g
97%
in stock  
$35.00   $25.00
- +
500g
97%
in stock  
$325.00   $227.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0003AY
Chemical Name:
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-
CAS Number:
100986-85-4
Molecular Formula:
C18H20FN3O4
Molecular Weight:
361.3675
MDL Number:
MFCD00865049
SMILES:
CN1CCN(CC1)c1c(F)cc2c3c1OC[C@@H](n3cc(c2=O)C(=O)O)C
NSC Number:
758709
Properties
Properties
 
BP:
571.5°C at 760 mmHg  
Form:
Solid  
MP:
218°C  
Solubility:
chloroform: soluble10mg/mL  
Stability:
Light Sensitive  
Storage:
2-8℃;  

Computed Properties
 
Complexity:
634  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
XLogP3:
-0.4  

Downstream Synthesis Route

[1]Patent:CN103755722,2016,B.Locationinpatent:Paragraph0052-0053

[2]LettersinOrganicChemistry,2018,vol.15,p.739-746

[3]RussianJournalofGeneralChemistry,2016,vol.86,p.2865-2869    Zh.Obshch.Khim.,2016,vol.86,p.2865-2869,5

[4]JournalofMedicinalChemistry,1987,vol.30,p.2283-2286

[5]Patent:EP368410,1990,A3

[6]Patent:US2004/152701,2004,A1.Locationinpatent:Page/Pagecolumn2-3

[7]Patent:US2003/130507,2003,A1

[8]Patent:US2003/130507,2003,A1

[9]Patent:US2003/130507,2003,A1

[10]Patent:US2003/130507,2003,A1

[11]Patent:US2003/130507,2003,A1

[12]Patent:WO2006/30452,2006,A1.Locationinpatent:Page/Pagecolumn5

[13]Patent:CN103360410,2016,B.Locationinpatent:Paragraph0019;0033;0034

[14]Patent:CN107118223,2017,A.Locationinpatent:Paragraph0020;0024;0028

[15]Patent:CN107163063,2017,A.Locationinpatent:Paragraph0020;0024;0028

[16]Patent:CN107141306,2017,A.Locationinpatent:Paragraph0020;0024;0028

[1]Chirality,2012,vol.24,p.661-667

[2]JournaloftheChineseChemicalSociety,2007,vol.54,p.991-995

[3]JournaloftheChileanChemicalSociety,2011,vol.56,p.642-645

[4]Chirality,2013,vol.25,p.409-414

[5]JournalofInclusionPhenomenaandMacrocyclicChemistry,2013,vol.77,p.291-300

[6]Chirality,2015,vol.27,p.306-313

[7]Patent:CN103664998,2016,B.Locationinpatent:Paragraph0020;0021

[8]Chirality,2018,vol.30,p.828-836

[9]Chirality,2018,vol.30,p.1304-1311

[10]ChineseChemicalLetters,2019,vol.30,p.643-649

109-01-3   
(3S)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido1,2,3-de1,4benzoxazine-6-carboxylicacid-borondifluoridechelatecomplex 
  100986-85-4 

[1]Patent:EP1367132,2003,A1.Locationinpatent:Page17

100986-85-4   
(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido1,2,3-de-1,4-benzoxazine-6-carboxylicacidhemihydrate 

[1]Patent:WO2006/9374,2006,A1.Locationinpatent:Page/Pagecolumn4

[2]Patent:WO2006/9374,2006,A1.Locationinpatent:Page/Pagecolumn4

[3]Patent:WO2006/9374,2006,A1.Locationinpatent:Page/Pagecolumn4

[4]Patent:WO2006/9374,2006,A1.Locationinpatent:Page/Pagecolumn5-6

[5]Patent:WO2006/9374,2006,A1.Locationinpatent:Page/Pagecolumn6

[6]Patent:WO2006/30452,2006,A1.Locationinpatent:Page/Pagecolumn5-6

[7]Patent:WO2006/48889,2006,A1.Locationinpatent:Page/Pagecolumn12-14;19

[1]Patent:US2003/144511,2003,A1

Literature

Title: Siva, R., et al., Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis, 2014. 9: p. 179-86.

Title: Pradeep, A.R., et al., Clinical and microbiological effects of levofloxacin in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. J Investig Clin Dent, 2014.

Title: Lee, B.T., et al., Efficacy of Levofloxacin in the Treatment of BK Viremia: A Multicenter, Double-Blinded, Randomized, Placebo-Controlled Trial. Clin J Am Soc Nephrol, 2014.

Title: Drlica K, et al. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92.

Title: Smee DF, et al. A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Res. 2003 Jan;57(1-2):41-52.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:100986-85-4 Molecular Formula|100986-85-4 MDL|100986-85-4 SMILES|100986-85-4 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-